BioLegend is a global trusted partner of premier research institutions, universities, industry associations, and biotech and pharmaceutical companies. Our cutting-edge, high-quality reagents and tools are developed by a team of expert scientists, giving researchers the confidence of delivering reliable and reproducible results in immunology, oncology, neuroscience, stem cells, and multiomics. BioLegend’s antibodies and research products have more than 80,000 citations in biomedical journals. Our dynamically expanding diagnostic products portfolio includes ASR and IVD reagents for flow cytometry and immunohistochemistry in the United States, and CE-marked diagnostic reagents for EU markets. Recognized as one of the fastest-growing life science companies, BioLegend transforms the boundaries of innovation for basic science and medical researchers worldwide.
Manufacturing and Qualification Challenges for Cell and Gene Therapy Products and Best Practices for Success
As a growing number of cell and gene therapies (CGTs) advance through clinical trials toward approval, the industry is striving to establish robust and well-characterized biomanufacturing processes. Raw materials for CGT manufacturing must comply with ... Continued
Chimeric antigen receptor (CAR)-T cell therapy has undeniably transformed modern medicine in the fight against cancer. This cell therapy uses patient (autologous) or donor (allogenic) T cells that have been modified to recognize and attack ... Continued
We formulated Cell-Vive™ T-NK Xeno-Free Serum Substitute to specifically culture and expand T cells and NK cells, adding the GMP seal to ensure suitability for research or cell bioprocessing....Continued